Cargando…

Enhanced serum immunoglobulin G clearance in myotonic dystrophy-associated hypogammaglobulinemia: a case series and review of the literature

BACKGROUND: Myotonic dystrophy type 1 is an autosomal dominant disorder characterized by muscle weakness, myotonia, cataracts, and cardiac conduction defects; it is associated with expansions of cytosine-thymine-guanine repeats in the myotonic dystrophy protein kinase. Hypogammaglobulinemia is a les...

Descripción completa

Detalles Bibliográficos
Autores principales: Sasson, Sarah C., Corbett, Alastair, McLachlan, Andrew J., Chen, R., Adelstein, S. A., Riminton, Sean, Limaye, Sandhya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6864924/
https://www.ncbi.nlm.nih.gov/pubmed/31744540
http://dx.doi.org/10.1186/s13256-019-2285-3
_version_ 1783471988733378560
author Sasson, Sarah C.
Corbett, Alastair
McLachlan, Andrew J.
Chen, R.
Adelstein, S. A.
Riminton, Sean
Limaye, Sandhya
author_facet Sasson, Sarah C.
Corbett, Alastair
McLachlan, Andrew J.
Chen, R.
Adelstein, S. A.
Riminton, Sean
Limaye, Sandhya
author_sort Sasson, Sarah C.
collection PubMed
description BACKGROUND: Myotonic dystrophy type 1 is an autosomal dominant disorder characterized by muscle weakness, myotonia, cataracts, and cardiac conduction defects; it is associated with expansions of cytosine-thymine-guanine repeats in the myotonic dystrophy protein kinase. Hypogammaglobulinemia is a lesser known association of myotonic dystrophy type 1 and the underlying pathogenesis of immunoglobulin G depletion remains unclear. CASE PRESENTATION: Here we report a kindred of two members (a 62-year-old white woman and a 30-year-old white man; mother and son) with myotonic dystrophy type 1-associated hypogammaglobulinemia associated with altered intravenous immunoglobulin elimination kinetics and reduced half-life. There was no history of systemic immunosuppression or renal or gastrointestinal protein loss in either patient, and no underlying case for a secondary immunodeficiency could be found. One patient required fortnightly intravenous immunoglobulin to maintain adequate trough immunoglobulin G levels. CONCLUSIONS: Ongoing study of myotonic dystrophy type 1-associated hypogammaglobulinemia using contemporary tools of genomic medicine may help to further delineate the pathogenesis of this entity.
format Online
Article
Text
id pubmed-6864924
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-68649242019-12-12 Enhanced serum immunoglobulin G clearance in myotonic dystrophy-associated hypogammaglobulinemia: a case series and review of the literature Sasson, Sarah C. Corbett, Alastair McLachlan, Andrew J. Chen, R. Adelstein, S. A. Riminton, Sean Limaye, Sandhya J Med Case Rep Case Report BACKGROUND: Myotonic dystrophy type 1 is an autosomal dominant disorder characterized by muscle weakness, myotonia, cataracts, and cardiac conduction defects; it is associated with expansions of cytosine-thymine-guanine repeats in the myotonic dystrophy protein kinase. Hypogammaglobulinemia is a lesser known association of myotonic dystrophy type 1 and the underlying pathogenesis of immunoglobulin G depletion remains unclear. CASE PRESENTATION: Here we report a kindred of two members (a 62-year-old white woman and a 30-year-old white man; mother and son) with myotonic dystrophy type 1-associated hypogammaglobulinemia associated with altered intravenous immunoglobulin elimination kinetics and reduced half-life. There was no history of systemic immunosuppression or renal or gastrointestinal protein loss in either patient, and no underlying case for a secondary immunodeficiency could be found. One patient required fortnightly intravenous immunoglobulin to maintain adequate trough immunoglobulin G levels. CONCLUSIONS: Ongoing study of myotonic dystrophy type 1-associated hypogammaglobulinemia using contemporary tools of genomic medicine may help to further delineate the pathogenesis of this entity. BioMed Central 2019-11-20 /pmc/articles/PMC6864924/ /pubmed/31744540 http://dx.doi.org/10.1186/s13256-019-2285-3 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Case Report
Sasson, Sarah C.
Corbett, Alastair
McLachlan, Andrew J.
Chen, R.
Adelstein, S. A.
Riminton, Sean
Limaye, Sandhya
Enhanced serum immunoglobulin G clearance in myotonic dystrophy-associated hypogammaglobulinemia: a case series and review of the literature
title Enhanced serum immunoglobulin G clearance in myotonic dystrophy-associated hypogammaglobulinemia: a case series and review of the literature
title_full Enhanced serum immunoglobulin G clearance in myotonic dystrophy-associated hypogammaglobulinemia: a case series and review of the literature
title_fullStr Enhanced serum immunoglobulin G clearance in myotonic dystrophy-associated hypogammaglobulinemia: a case series and review of the literature
title_full_unstemmed Enhanced serum immunoglobulin G clearance in myotonic dystrophy-associated hypogammaglobulinemia: a case series and review of the literature
title_short Enhanced serum immunoglobulin G clearance in myotonic dystrophy-associated hypogammaglobulinemia: a case series and review of the literature
title_sort enhanced serum immunoglobulin g clearance in myotonic dystrophy-associated hypogammaglobulinemia: a case series and review of the literature
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6864924/
https://www.ncbi.nlm.nih.gov/pubmed/31744540
http://dx.doi.org/10.1186/s13256-019-2285-3
work_keys_str_mv AT sassonsarahc enhancedserumimmunoglobulingclearanceinmyotonicdystrophyassociatedhypogammaglobulinemiaacaseseriesandreviewoftheliterature
AT corbettalastair enhancedserumimmunoglobulingclearanceinmyotonicdystrophyassociatedhypogammaglobulinemiaacaseseriesandreviewoftheliterature
AT mclachlanandrewj enhancedserumimmunoglobulingclearanceinmyotonicdystrophyassociatedhypogammaglobulinemiaacaseseriesandreviewoftheliterature
AT chenr enhancedserumimmunoglobulingclearanceinmyotonicdystrophyassociatedhypogammaglobulinemiaacaseseriesandreviewoftheliterature
AT adelsteinsa enhancedserumimmunoglobulingclearanceinmyotonicdystrophyassociatedhypogammaglobulinemiaacaseseriesandreviewoftheliterature
AT rimintonsean enhancedserumimmunoglobulingclearanceinmyotonicdystrophyassociatedhypogammaglobulinemiaacaseseriesandreviewoftheliterature
AT limayesandhya enhancedserumimmunoglobulingclearanceinmyotonicdystrophyassociatedhypogammaglobulinemiaacaseseriesandreviewoftheliterature